BANK OF AMERICA CORP /DE/
BankPosition in XENE — Xenon Pharmaceuticals Inc.
CIK 70858
CHARLOTTE, NC
Position in XENE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,389,482
+$8,964,208 QoQ
Shares Held
404,067
+52.3% QoQ
Ownership
0.417%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 314 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 44%
Shared 0%
None 56%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Derivatives in XENE
reported options exposure · as of Dec 31, 2023CallValue
$5,384,414
CallShares
116,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. XENE ranks #78 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in XENE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,389,482 | 404,067 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $15,425,274 | 265,267 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $9,921,711 | 221,368 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,994,103 | 199,106 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $11,218,919 | 358,432 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,581,887 | 136,569 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,190,713 | 106,906 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,017,940 | 127,456 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,549,522 | 142,332 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,763,325 | 157,104 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,144,954 | 133,412 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $5,384,414 | 116,900 | Call | Defined | 2024-02-14 | |
| 2023-09-30 | $4,234,710 | 123,967 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,135,975 | 159,376 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,799,831 | 134,111 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,499,332 | 88,748 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $974,518 | 26,995 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,115,043 | 36,655 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $191,948 | 6,279 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,337,008 | 42,798 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $219,832 | 14,387 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $129,947 | 6,979 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $309,167 | 17,272 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $43,955 | 2,858 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $37,006 | 3,343 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $44,266 | 3,530 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||